Long-term follow up after coronary sirolimus drug-eluting stent implantation for cardiac transplant arteriopathy.
There has been limited published experience with the use of sirolimus drug-eluting stents in the setting of cardiac transplant vasculopathy. Systemic sirolimus has been shown to protect against progressive transplant vasculopathy, and sirolimus-eluting stents have shown to reduce the risk of in-stent restenosis in native coronary arteries. We report a case of acute myocardial infarction in the setting of advanced transplant vasculopathy, and describe the long-term results of sirolimus drug-eluting stent implantation.
Yoon
Edward J
EJ
California Pacific Medical Center, San Francisco, California, USA.
Haeusslein
Ernest
E
Brent
Bruce
B
D017023:Coronary Angiography; D003324:Coronary Artery Disease / Q000000981:diagnostic imaging / Q000209:etiology* / Q000628:therapy*; D023903:Coronary Restenosis / Q000000981:diagnostic imaging / Q000209:etiology; D005500:Follow-Up Studies; D016027:Heart Transplantation / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000209:etiology; D020123:Sirolimus / Q000008:administration & dosage*; D015607:Stents / Q000009:adverse effects; D016896:Treatment Outcome
D020123:Sirolimus